Advances in the design and delivery of RNA vaccines for infectious diseases
Advanced Drug Delivery Reviews · 2024
DOI: 10.1016/j.addr.2024.115419 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024. Verfasst von Abhijeet Girish Lokras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, mRNA Vaccines. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 399 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Independent Research Fund Denmark, Danmarks Frie Forskningsfond, Novo Nordisk Foundation.
Abstract (Originalsprache)
RNA medicines represent a paradigm shift in treatment and prevention of critical diseases of global significance, e.g., infectious diseases. The highly successful messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed at record speed during the coronavirus disease 2019 pandemic. A consequence of this is exceptionally shortened vaccine development times, which in combination with adaptability makes the RNA vaccine technology highly attractive against infectious diseases and for pandemic preparedness. Here, we review state of the art in the design and delivery of RNA vaccines for infectious diseases based on different RNA modalities, including linear mRNA, self-amplifying RNA, trans-amplifying RNA, and circular RNA. We provide an overview of the clinical pipeline of RNA vaccines for infectious diseases, and present analytical procedures, which are paramount for characterizing quality attributes and guaranteeing their quality, and we discuss future perspectives for using RNA vaccines to combat pathogens beyond SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark.
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark; Division of Physical Chemistry, Department of Chemistry, Lund University, 22100…
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark. Electronic address: camilla.foged@sund.ku.dk.
Förderung
- Independent Research Fund Denmark
- Danmarks Frie Forskningsfond
- Novo Nordisk Foundation
Zitieren
APA
Lokras, A. G., Bobak, T. R., Baghel, S. S., Sebastiani, F., & Foged, C. (2024). Advances in the design and delivery of RNA vaccines for infectious diseases. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2024.115419
Vancouver
Lokras AG, Bobak TR, Baghel SS, Sebastiani F, Foged C. Advances in the design and delivery of RNA vaccines for infectious diseases. Advanced Drug Delivery Reviews. 2024. doi:10.1016/j.addr.2024.115419
BibTeX
@article{Lokras2024,
author = {Lokras, Abhijeet Girish and Bobak, Thomas Rønnemoes and Baghel, Saahil Sandeep and Sebastiani, Federica and Foged, Camilla},
title = {Advances in the design and delivery of RNA vaccines for infectious diseases},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
doi = {10.1016/j.addr.2024.115419}
}
EUVIMED